E. H. Dugoff, V. Canudas-romo, C. Buttorff, B. Leff, and G. F. Anderson, Multiple chronic conditions and life expectancy, Med. Care, vol.52, pp.688-694, 2014.

K. Barnett, Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study, Lancet, vol.380, pp.37-43, 2012.

S. Cortaredona and B. Ventelou, The extra cost of comorbidity: multiple illnesses and the economic burden of non-communicable diseases, BMC Med, vol.15, p.216, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01660137

T. Lancet and T. , Making more of multimorbidity: an emerging priority, Lancet, vol.391, p.1637, 2018.

J. Ji, Incidence of cancer in patients with schizophrenia and their firstdegree relatives: a population-based study in Sweden, Schizophr. Bull, vol.39, pp.527-536, 2013.

K. Goh, The human disease network, Proc. Natl. Acad. Sci. USA, vol.104, pp.8685-8690, 2007.

G. Hu and P. Agarwal, Human disease-drug network based on genomic expression profiles, PLoS ONE, vol.4, p.6536, 2009.

J. Menche, Uncovering disease?disease relationships through the incomplete interactome, Science, vol.347, pp.1257601-1257601, 2015.

M. Lu, An analysis of human microRNA and disease associations, PLoS ONE, vol.3, p.3420, 2008.

W. Ma, An analysis of human microbe-disease associations, Brief. Bioinform, vol.18, pp.85-97, 2017.

C. A. Hidalgo, N. Blumm, A. Barabási, and N. A. Christakis, A dynamic network approach for the study of human phenotypes, PLoS Comput. Biol, vol.5, p.1000353, 2009.

M. K. Beck, Diagnosis trajectories of prior multi-morbidity predict sepsis mortality, Sci. Rep, vol.6, p.36624, 2016.

X. Zhou, J. Menche, A. Barabási, and A. Sharma, Human symptoms-disease network, Nat. Commun, vol.5, p.4212, 2014.

K. Wang, H. Gaitsch, H. Poon, N. J. Cox, and A. Rzhetsky, Classification of common human diseases derived from shared genetic and environmental determinants, Nat. Genet, vol.49, pp.1319-1325, 2017.

J. Piñero, DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants, Nucleic Acids Res, vol.45, pp.833-839, 2017.

J. Park, D. Lee, N. A. Christakis, and A. Barabási, The impact of cellular networks on disease comorbidity, Mol. Syst. Biol, vol.5, p.262, 2009.

J. X. Hu, C. E. Thomas, and S. Brunak, Network biology concepts in complex disease comorbidities, Nat. Rev. Genet, vol.17, pp.615-629, 2016.

M. Barrecheguren and M. Miravitlles, COPD heterogeneity: implications for management, Multidiscip. Respir. Med, vol.11, p.14, 2016.

C. M. Perou, Molecular portraits of human breast tumours, Nature, vol.406, pp.747-752, 2000.

M. Weiser, Molecular classification of Crohn's disease reveals two clinically relevant subtypes, Gut, vol.67, pp.36-42, 2018.

, Deaths by Cause, Age, Sex, by Country and by Region, World Health Organizations, 2000.

A. B. Jensen, Temporal disease trajectories condensed from populationwide registry data covering 6.2 million patients, Nat. Commun, vol.5, p.4022, 2014.

K. Ibáñez, C. Boullosa, R. Tabarés-seisdedos, A. Baudot, and A. Valencia, Molecular evidence for the inverse comorbidity between central nervous system disorders and cancers detected by transcriptomic meta-analyses, PLoS Genet, vol.10, p.1004173, 2014.

J. Sánchez-valle, A molecular hypothesis to explain direct and inverse co-morbidities between Alzheimer's disease, glioblastoma and lung cancer, Sci. Rep, vol.7, p.4474, 2017.

X. Zhou, A systems approach to refine disease taxonomy by integrating phenotypic and molecular networks, EBioMedicine, vol.31, pp.79-91, 2018.

R. Tabarés-seisdedos and J. L. Rubenstein, Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders, Nat. Rev. Neurosci, vol.14, pp.293-304, 2013.

B. Liu and E. Taioli, Seasonal variations of complete blood count and inflammatory biomarkers in the US population-analysis of NHANES data, PLoS ONE, vol.10, p.142382, 2015.

S. Suthram, Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets, PLoS Comput. Biol, vol.6, p.1000662, 2010.

M. Musicco, Inverse occurrence of cancer and Alzheimer disease: a population-based incidence study, Neurology, vol.81, pp.322-328, 2013.

J. A. Driver, Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study, BMJ, vol.344, p.1442, 2012.

E. Ahlqvist, Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables, Lancet Diabetes Endocrinol, vol.6, pp.361-369, 2018.

A. J. Bass, Comprehensive molecular characterization of gastric adenocarcinoma, Nature, vol.513, pp.202-209, 2014.

. Cancer-genome-atlas and T. C. Network, Comprehensive genomic characterization of head and neck squamous cell carcinomas, Nature, vol.517, pp.576-582, 2015.

P. Klimek, S. Aichberger, and S. Thurner, Disentangling genetic and environmental risk factors for individual diseases from multiplex comorbidity networks, Sci. Rep, vol.6, p.39658, 2016.

B. Na, TAGLN2 regulates T cell activation by stabilizing the actin cytoskeleton at the immunological synapse, J. Cell Biol, vol.209, pp.143-162, 2015.

T. C. Durazzo, N. Mattsson, and M. W. Weiner, Alzheimer's Disease Neuroimaging Initiative. Smoking and increased Alzheimer's disease risk: a review of potential mechanisms, vol.10, pp.122-145, 2014.

R. Hu, MicroRNA-10a controls airway smooth muscle cell proliferation via direct targeting of the PI3 kinase pathway, FASEB J, vol.28, pp.2347-2357, 2014.

T. Yu, MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN, Oncotarget, vol.6, pp.30239-30250, 2015.

A. Bruno, The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer, Neoplasia, vol.15, pp.133-142, 2013.

F. Jadidi-niaragh, H. Shegarfi, F. Naddafi, and A. Mirshafiey, The role of natural killer cells in Alzheimer's disease, Scand. J. Immunol, vol.76, pp.451-456, 2012.

S. Cunnane, Brain fuel metabolism, aging, and Alzheimer's disease, Nutrition, vol.27, pp.3-20, 2011.
URL : https://hal.archives-ouvertes.fr/hal-02309749

A. Giatromanolaki, E. Sivridis, S. Arelaki, and M. I. Koukourakis, Expression of enzymes related to glucose metabolism in non-small cell lung cancer and prognosis, Exp. Lung Res, vol.43, pp.167-174, 2017.

A. Fabregat, The reactome pathway knowledgebase, Nucleic Acids Res, vol.46, pp.649-655, 2018.

M. Kanehisa and S. Goto, KEGG: kyoto encyclopedia of genes and genomes, Nucleic Acids Res, vol.28, pp.27-30, 2000.

M. Ashburner, Gene Ontology: tool for the unification of biology, Nat. Genet, vol.25, pp.25-29, 2000.

Y. Yang, Protein SUMOylation modification and its associations with disease, Open Biol, vol.7, p.170167, 2017.

N. S. Jahchan, A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors, Cancer Discov, vol.3, pp.1364-1377, 2013.

F. Iorio, Discovery of drug mode of action and drug repositioning from transcriptional responses, Proc. Natl. Acad. Sci. USA, vol.107, p.14621, 2010.

D. P. Devanand, A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease, Am. J. Psychiatry, vol.155, pp.1512-1520, 1998.

B. M. Bolea-alamanac, Cyproterone to treat aggressivity in dementia: a clinical case and systematic review, J. Psychopharmacol, vol.25, pp.141-145, 2011.

A. Cesano and S. Warren, Bringing the next generation of immuno-oncology biomarkers to the clinic, Biomedicines, vol.6, p.14, 2018.

N. D. Price, A wellness study of 108 individuals using personal, dense, dynamic data clouds, Nat. Biotechnol, vol.35, pp.747-756, 2017.

, Multimorbidity: A Priority for Global Health Research (The Academy of, The Academy of Medical Sciences, 2018.

M. N. Mccall, H. A. Jaffee, and R. A. Irizarry, fRMA ST: frozen robust multiarray analysis for Affymetrix Exon and Gene ST arrays, Bioinformatics, vol.28, pp.3153-3154, 2012.

M. E. Ritchie, limma powers differential expression analyses for RNAsequencing and microarray studies, Nucleic Acids Res, vol.43, p.47, 2015.

O. Bodenreider, The Unified Medical Language System (UMLS): Integrating biomedical terminology, Nucleic Acids Res, vol.32, pp.267-270, 2004.

P. J. Rousseeuw, Silhouettes: a graphical aid to the interpretation and validation of cluster analysis, J. Comput. Appl. Math, vol.20, pp.53-65, 1987.

J. A. Hartigan and M. A. Wong, Algorithm AS 136: a K-means clustering algorithm, Appl. Stat, vol.28, p.100, 1979.

A. Subramanian, A next generation connectivity map: L1000 platform and the first 1,000,000 profiles, Cell, vol.171, pp.1437-1452, 2017.

A. Sergushichev, An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation, 2016.

W. Mckinney, Data structures for statistical computing in Python, Proc. 9th Python in Science Conf, vol.445, pp.51-56, 2010.

M. Franz, js: a graph theory library for visualisation and analysis, Bioinformatics, vol.32, p.557, 2015.